Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 6, Pages 2982
Publisher
MDPI AG
Online
2021-03-15
DOI
10.3390/ijms22062982
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment
- (2020) Belén Delgado‐Martín et al. Advanced Science
- Higher levels of dynamin-related protein 1 are associated with reduced radiation sensitivity of glioblastoma cells
- (2020) Wen-Yu Cheng et al. CURRENT NEUROVASCULAR RESEARCH
- The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
- (2020) Jacopo Boni et al. Cancers
- Therapeutic potential of targeting mitochondrial dynamics in cancer
- (2020) Tiago Rodrigues et al. BIOCHEMICAL PHARMACOLOGY
- Dyrk3 loss activates the purine metabolism and promotes hepatocellular carcinoma progression
- (2019) Fei Ma et al. HEPATOLOGY
- Mitochondrial Dynamics: Biogenesis, Fission, Fusion, and Mitophagy in the Regulation of Stem Cell Behaviors
- (2019) Wenyan Fu et al. Stem Cells International
- Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
- (2019) Lin-wen Wu et al. OncoTargets and Therapy
- Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma
- (2019) Beomseok Son et al. ONCOGENE
- Mitochondrial dynamics: overview of molecular mechanisms
- (2018) Lisa Tilokani et al. Essays in Biochemistry
- Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
- (2018) Subhamoy Dasgupta et al. NATURE
- LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy
- (2018) Gaeul Park et al. MOLECULAR THERAPY
- Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis
- (2017) Yingying Chen et al. HUMAN PATHOLOGY
- mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1
- (2017) Masahiro Morita et al. MOLECULAR CELL
- Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics
- (2017) Fuxin Yi et al. OncoTargets and Therapy
- TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation
- (2016) J Kang et al. ONCOGENE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Oncogenic regulation of tumor metabolic reprogramming
- (2016) Míriam Tarrado-Castellarnau et al. Oncotarget
- Mitochondrial Mechanisms of Metabolic Reprogramming in Proliferating Cells
- (2015) Maria Sousa et al. CURRENT MEDICINAL CHEMISTRY
- 3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties
- (2015) Céline Meinguet et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Durability of Kinase-Directed Therapies--A Network Perspective on Response and Resistance
- (2015) B. W. Murray et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial Division Is Requisite to RAS-Induced Transformation and Targeted by Oncogenic MAPK Pathway Inhibitors
- (2015) Madhavika N. Serasinghe et al. MOLECULAR CELL
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Mitochondrial control by DRP1 in brain tumor initiating cells
- (2015) Qi Xie et al. NATURE NEUROSCIENCE
- Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation
- (2015) Mahmoud Toulany et al. SEMINARS IN CANCER BIOLOGY
- DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma
- (2015) Noriko Yamaguchi et al. TUMOR BIOLOGY
- Mitochondrial Dynamics Protein Drp1 Is Overexpressed in Oncocytic Thyroid Tumors and Regulates Cancer Cell Migration
- (2015) André Ferreira-da-Silva et al. PLoS One
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells
- (2014) YU-YING WAN et al. ONCOLOGY REPORTS
- Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
- (2014) Qiang Liu et al. PLoS One
- Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines
- (2014) Joshua C. Anderson et al. RADIOTHERAPY AND ONCOLOGY
- DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail
- (2013) Rei Mimoto et al. CANCER LETTERS
- The DREAM Complex Mediates GIST Cell Quiescence and Is a Novel Therapeutic Target to Enhance Imatinib-Induced Apoptosis
- (2013) S. Boichuk et al. CANCER RESEARCH
- Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling
- (2013) Frank Wippich et al. CELL
- Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle
- (2013) Jia-Yun Chen et al. MOLECULAR CELL
- Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology
- (2012) Tatiana I. Slepak et al. Cytoskeleton
- DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells
- (2012) Naoe Taira et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial dynamics regulates migration and invasion of breast cancer cells
- (2012) J Zhao et al. ONCOGENE
- Psoralidin, a dual inhibitor of COX-2 and 5-LOX, regulates ionizing radiation (IR)-induced pulmonary inflammation
- (2011) Hee Jung Yang et al. BIOCHEMICAL PHARMACOLOGY
- The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer
- (2011) Jingchun Gao INTERNATIONAL JOURNAL OF ONCOLOGY
- Mitochondria in cancer: at the crossroads of life and death
- (2011) Vanessa C. Fogg et al. Chinese Journal of Cancer
- DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
- (2010) Xiumei Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting multiple kinases in glioblastoma multiforme
- (2009) Sith Sathornsumetee et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now